[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100636715":3},{"organization":4,"outcomesModule":7,"designInfo":23,"detailedDescription":22,"studyPopulation":22,"armGroups":31,"interventions":44,"overallOfficials":22,"centralContacts":52,"locations":58,"responsibleParty":77,"collaborators":22,"id":79,"slug":22,"hasResults":80,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":22,"eligibilityCriteria":84,"healthyVolunteers":80,"sex":85,"minAge":86,"maxAge":87,"enrollmentInfo":88,"targetDuration":22,"studyType":91,"phases":92,"briefSummary":94,"conditions":95,"keywords":97,"overallStatus":102,"whyStopped":22,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":112},{"fullName":5,"class":6},"Bedaya Hospital","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":22},[9],{"measure":10,"description":11,"timeFrame":12},"Metaphase-II oocytes rate","Number of MII oocyte\u002F number of cumulus oocyte complex","Ten to fifteen days after starting ovarian stimulation",[14,18],{"measure":15,"description":16,"timeFrame":17},"Clinical pregnancy rate","Presence of intrauterine gestational sac detected by transvaginal ultrasound","Five weeks after embryo transfer",{"measure":19,"description":20,"timeFrame":21},"Ongoing pregnancy Rate","Pregnancies continued beyond 20 weeks gestation","Eighteen weeks after embryo transfer",null,{"allocation":24,"interventionModel":25,"interventionModelDescription":22,"primaryPurpose":26,"observationalModel":22,"timePerspective":22,"maskingInfo":27},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":28,"maskingDescription":22,"whoMasked":29},"SINGLE",[30],"OUTCOMES_ASSESSOR",[32,38],{"label":33,"type":34,"description":35,"interventionNames":36},"Double trigger","EXPERIMENTAL","GnRH agonist is administered 38 - 39 hours prior to ovum pick-up and HCG is administered 35 - 36 hours prior to ovum pick-up, respectively.",[37],"Drug: Double trigger",{"label":39,"type":40,"description":41,"interventionNames":42},"HCG trigger","ACTIVE_COMPARATOR","HCG is administered 35 - 36 h prior to ovum pick-up",[43],"Drug: HCG trigger",[45,49],{"type":46,"name":33,"description":47,"armGroupLabels":48,"otherNames":22},"DRUG","Triptorelin (0.2 mg\u002FS.C ) and HCG (10000 IU\u002FI.M) are administered 38 to 39 h and 35 to 36 h prior to ovum pick-up., respectively.",[33],{"type":46,"name":39,"description":50,"armGroupLabels":51,"otherNames":22},"HCG (10000 IU\u002FI.M) is administered 35 to 36 h prior to ovum pick-up.",[39],[53],{"name":54,"role":55,"phone":56,"phoneExt":22,"email":57},"Usama M Fouda, Prof.","CONTACT","+201095401375","umfrfouda@yahoo.com",[59],{"facility":5,"status":22,"city":60,"state":61,"zip":62,"country":63,"countryCode":64,"cosmosGeoPoint":65,"geoPoint":70,"contacts":71},"Giza","Giza Governorate","3753303","Egypt","EG",{"type":66,"coordinates":67},"Point",[68,69],31.20861,30.00944,{"lat":69,"lon":68},[72,74],{"name":73,"role":55,"phone":56,"phoneExt":22,"email":57},"Usama M Fouda, Prof",{"name":75,"role":76,"phone":22,"phoneExt":22,"email":22},"Reham Elkhalifa, M.D, PhD","PRINCIPAL_INVESTIGATOR",{"type":78,"investigatorFullName":22,"investigatorTitle":22,"investigatorAffiliation":22,"oldNameTitle":22,"oldOrganization":22},"SPONSOR","100636715",false,"NCT07569289","Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger","Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger . A Randomized Controlled Study","Inclusion Criteria:\n\n* POSEIDON group 3 and 4\n* GnRH antagonist IVF cycle\n\nExclusion Criteria:\n\n* Hypogonadotrophic hypogonadism\n* Endometriosis\n* History of recurrent abortion","FEMALE","18 Years","40 Years",{"count":89,"type":90},164,"ESTIMATED","INTERVENTIONAL",[93],"PHASE2","The aim of this randomized controlled study is to compare the efficacy of double trigger protocol \\[ the co-administration of GnRH agonist with HCG ( 38 - 39 and 35 - 36 h prior to ovum pick-up, respectively \\] with HCG in triggering ovulation in patients with expected poor response to ovarian stimulation",[96],"Infertility",[96,98,99,100,101,33],"Poor responders","IVF-ET","HCG","GnRH agonist","NOT_YET_RECRUITING","2026-04-29",{"date":105,"type":106},"2026-05-06","ACTUAL",{"date":108,"type":90},"2026-06-01",{"date":110,"type":90},"2028-04-01",{"name":5,"class":6},1]